ATAI Life Sciences NV (STU:9VC)
€ 1.0905 0.1125 (11.5%) Market Cap: 181.10 Mil Enterprise Value: 118.25 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 44/100

Q4 2021 ATAI Life Sciences NV Earnings Call Transcript

Mar 30, 2022 / 12:30PM GMT
Release Date Price: €4.86 (+5.42%)
Unidentified Company Representative

Good morning, and welcome to atai Life Sciences Fourth Quarter and Year-End 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions) Visit the live webcast via the News & Events section of company's website at www.atai.life and is being recorded. A replay of the webcast will be available on our website.

Joining me today are Florian Brand, Chief Executive Officer and Co-Founder; and Dr. Srini Rao, Chief Scientific Officer and Co-Founder.

The press release announcing our financial results is available on atai's website. Please take a moment to read the disclaimer about forward-looking statements in the press release.

During today's call, we'll make certain forward-looking statements that are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 for forward-looking statements. While these statements represent management's current expectations and projections about future results and performance, atai's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot